You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DLL4

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioma Trial (BI 764532)

Not yet recruiting
  • Glioma
  • BI 764532
  • (no location specified)
Jun 15, 2023

Advanced Solid Tumors Trial in Seongnam-si, Seoul (NOV1501 (ABL001))

Completed
  • Advanced Solid Tumors
  • NOV1501 (ABL001)
  • Seongnam-si, Korea, Republic of
  • +1 more
Jul 4, 2021

Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)

Recruiting
  • Small Cell Lung Carcinoma
  • AMG 757
  • +2 more
  • Duarte, California
  • +34 more
Dec 6, 2022

Stroke, Acute, Stroke, Ischemic Trial in Beijing (LF-rTMS)

Not yet recruiting
  • Stroke, Acute
  • Stroke, Ischemic
  • LF-rTMS
  • Beijing, Beijing, China
    Beijing Tian tan Hospital
Sep 26, 2023

Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)

Recruiting
  • Diabetic Nephropathies
  • Boston, Massachusetts
  • +1 more
Aug 15, 2022

Small Cell Lung Cancer Trial (Rovalpituzumab tesirine)

Completed
Has Results
  • Small Cell Lung Cancer
  • Rovalpituzumab tesirine
  • (no location specified)
Jul 28, 2021

Stroke, Acute Ischemic Trial in Beijing (LF-rTMS, Sham stimulation)

Not yet recruiting
  • Stroke, Acute Ischemic
  • LF-rTMS
  • Sham stimulation
  • Beijing, Beijing, China
    Beijing Tian tan Hospital
Sep 26, 2023

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Los Angeles, California
  • +37 more
Feb 1, 2023

Small Cell Lung Cancer Trial in Worldwide (Rovalpituzumab tesirine, Topotecan, Dexamethasone)

Completed
Has Results
  • Small Cell Lung Cancer
  • Rovalpituzumab tesirine
  • +2 more
  • Huntsville, Alabama
  • +194 more
Feb 19, 2021

Wound Heal, Diabetic Foot Ulcer, Ozone Trial (Topical ozone therapy)

Not yet recruiting
  • Wound Heal
  • +2 more
  • Topical ozone therapy
  • (no location specified)
Jul 28, 2023

Retinopathy of Prematurity Trial in Brooklyn (Caffeine citrate, Ibuprofen, Ketorolac)

Completed
Has Results
  • Retinopathy of Prematurity
  • Caffeine citrate
  • +2 more
  • Brooklyn, New York
    SUNY Downstate Medical Center/University Hospital of Brooklyn
Apr 21, 2020

Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab

Terminated
Has Results
  • Small Cell Lung Cancer
  • Placebo for dexamethasone
  • +3 more
  • Huntsville, Alabama
  • +307 more
Jul 28, 2021

Small Cell Lung Cancer Trial in United States (Rovalpituzumab Tesirine, Cisplatin, Etoposide)

Terminated
  • Small Cell Lung Cancer
  • Rovalpituzumab Tesirine
  • +2 more
  • Aurora, Colorado
  • +10 more
Mar 11, 2020

Gastrointestinal Vascular Malformation Trial in China (Thalidomide (100mg), Thalidomide (50mg), )

Unknown status
  • Gastrointestinal Vascular Malformation
  • Thalidomide (100mg)
  • +2 more
  • Beijing, Beijing, China
  • +10 more
Sep 19, 2019

Acute Ischaemic Stroke Trial in Sweden (Imatinib 400mg, Placebo Oral Tablet)

Recruiting
  • Acute Ischaemic Stroke
  • Imatinib 400mg
  • Placebo Oral Tablet
  • Eskilstuna, Sweden
  • +16 more
Sep 14, 2020

Small Cell Lung Cancer Trial in Worldwide (Dexamethasone, Rovalpituzumab tesirine)

Withdrawn
  • Small Cell Lung Cancer
  • Chandler, Arizona
  • +59 more
Dec 21, 2018

Small Cell Lung Carcinoma Trial in Canada, United States (Rovalpituzumab Tesirine)

Completed
  • Small Cell Lung Carcinoma
  • Rovalpituzumab Tesirine
  • Los Angeles, California
  • +14 more
Sep 20, 2018

Obstructive Sleep Apnea Trial (Advice in lifestyle, Cervical collar)

Unknown status
  • Obstructive Sleep Apnea
  • Advice in lifestyle
  • Cervical collar
  • (no location specified)
Nov 26, 2018

Breast Cancer Trial in United States (bevacizumab, Carboplatin, ABI-007)

Completed
Has Results
  • Breast Cancer
  • bevacizumab
  • +2 more
  • Downers Grove, Illinois
  • +5 more
Aug 16, 2017

Solid Tumors Trial in United States (MEDI0639)

Completed
Has Results
  • Solid Tumors
  • MEDI0639
  • Los Angeles, California
  • +10 more
Mar 21, 2017

Self Efficacy, Adverse Drug Event, Carcinoma, Renal Cell Trial in Guangzhou (pazopanib)

Unknown status
  • Self Efficacy
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Guangzhou Medical University
Dec 18, 2014

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
  • Estrogen Receptor-positive Breast Cancer
  • +4 more
  • Birmingham, Alabama
  • +2 more
Sep 27, 2013

Measurement of Immune Response to Prevenar13, Measurement of Immune Response to Hepatitis A Trial in Helsinki, Eskilstuna

Unknown status
  • Measurement of Immune Response to Prevenar13
  • Measurement of Immune Response to Hepatitis A
  • Prevenar13
  • Hepatitis A vaccine
  • Helsinki, Finland
  • +1 more
Aug 20, 2013